HC Wainwright & Co. analyst Amit Dayal downgrades Loop Industries (NASDAQ:LOOP) from Buy to Neutral.
Hillstream BioPharma Inks HER2 and HER3 License Deal With Applied Biomedical Science Institute For Potential Treatments Against Drug Resistant Cancers
Hillstream BioPharma, Inc. (NASDAQ:HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting drug resistant and devastating cancers using ferroptosis,